LVTX
Price
$1.38
Change
+$0.02 (+1.47%)
Updated
Apr 24 closing price
Capitalization
36.3M
19 days until earnings call
TCRX
Price
$1.73
Change
+$0.10 (+6.13%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
97.34M
18 days until earnings call
Ad is loading...

LVTX vs TCRX

Header iconLVTX vs TCRX Comparison
Open Charts LVTX vs TCRXBanner chart's image
LAVA Therapeutics
Price$1.38
Change+$0.02 (+1.47%)
Volume$10.64K
Capitalization36.3M
TScan Therapeutics
Price$1.73
Change+$0.10 (+6.13%)
Volume$7.04K
Capitalization97.34M
LVTX vs TCRX Comparison Chart
Loading...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LVTX vs. TCRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVTX is a Hold and TCRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (LVTX: $1.38 vs. TCRX: $1.72)
Brand notoriety: LVTX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LVTX: 2% vs. TCRX: 71%
Market capitalization -- LVTX: $36.3M vs. TCRX: $97.34M
LVTX [@Biotechnology] is valued at $36.3M. TCRX’s [@Biotechnology] market capitalization is $97.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LVTX’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 0 green FA rating(s).

  • LVTX’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, LVTX is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LVTX’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • LVTX’s TA Score: 5 bullish, 5 bearish.
  • TCRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both LVTX and TCRX are a good buy in the short-term.

Price Growth

LVTX (@Biotechnology) experienced а +5.34% price change this week, while TCRX (@Biotechnology) price change was +19.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

LVTX is expected to report earnings on Aug 26, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($97.3M) has a higher market cap than LVTX($36.3M). LVTX YTD gains are higher at: 45.110 vs. TCRX (-43.421). LVTX has higher annual earnings (EBITDA): -25.21M vs. TCRX (-119.74M). TCRX has more cash in the bank: 290M vs. LVTX (78.9M). LVTX has less debt than TCRX: LVTX (6.29M) vs TCRX (97.4M). LVTX has higher revenues than TCRX: LVTX (7.35M) vs TCRX (2.82M).
LVTXTCRXLVTX / TCRX
Capitalization36.3M97.3M37%
EBITDA-25.21M-119.74M21%
Gain YTD45.110-43.421-104%
P/E RatioN/AN/A-
Revenue7.35M2.82M261%
Total Cash78.9M290M27%
Total Debt6.29M97.4M6%
TECHNICAL ANALYSIS
Technical Analysis
LVTXTCRX
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KZR4.750.17
+3.71%
Kezar Life Sciences Inc
CRGY8.500.23
+2.78%
Crescent Energy Company
RDN31.910.30
+0.95%
Radian Group
LOCO9.48-0.02
-0.21%
El Pollo Loco Holdings
O57.15-0.90
-1.55%
Realty Income Corp

LVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVTX has been loosely correlated with BDRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LVTX jumps, then BDRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVTX
1D Price
Change %
LVTX100%
+1.47%
BDRX - LVTX
41%
Loosely correlated
+9.86%
TCRX - LVTX
32%
Poorly correlated
+5.52%
CYDY - LVTX
31%
Poorly correlated
-3.31%
CRVO - LVTX
28%
Poorly correlated
-2.44%
PCSA - LVTX
27%
Poorly correlated
-0.13%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with PRME. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+5.52%
PRME - TCRX
46%
Loosely correlated
-1.69%
FATE - TCRX
44%
Loosely correlated
+1.50%
IMNM - TCRX
43%
Loosely correlated
+0.24%
SYRE - TCRX
42%
Loosely correlated
+4.99%
IDYA - TCRX
41%
Loosely correlated
+1.33%
More